| Effect of Coadministration of Itraconazole on the Pharmacokinetics of CRD-740 (NCT05437094) | Cardurion Pharmaceuticals, Inc. | 2022-06-27 |
| Dose Study of ANX1502 in Healthy Volunteers (NCT05521269) | Annexon, Inc. | 2022-06-27 |
| Safety and Tolerability of SHR-1918 in Healthy Subjects (NCT05432544) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2022-06-27 |
| The Effect of Hepatic Impairment on the Pharmacokinetics of Balovaptan (NCT03912350) | Hoffmann-La Roche | 2022-06-26 |
| A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 12.5 mg and MET XR 500 mg) in Healthy Volunteers (NCT05363592) | Celltrion | 2022-06-25 |
| Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation (NCT04655391) | City of Hope Medical Center | 2022-06-25 |
| Study on the Pharmacokinetic Effect of Itraconazole on SHR0302 Tablets in Healthy Subjects (NCT05404724) | Jiangsu HengRui Medicine Co., Ltd. | 2022-06-25 |
| The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma (NCT05868083) | Shanghai Simnova Biotechnology Co.,Ltd. | 2022-06-24 |
| A Study of Belzutifan (MK-6482) in Participants With Hepatic Impairment (MK-6482-020) (NCT04995484) | Merck Sharp & Dohme LLC | 2022-06-24 |
| A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults (NCT05389319) | University Hospital Tuebingen | 2022-06-24 |
| Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients (NCT05274048) | Fox Chase Cancer Center | 2022-06-24 |
| Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists (NCT05338632) | Leiden University Medical Center | 2022-06-24 |
| A Clinical Trial to Evaluate the Effect of IAE0972 in Patients With Advanced Malignant Solid Tumors. (NCT05396339) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2022-06-24 |
| LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia (NCT05518357) | Hebei Yanda Ludaopei Hospital | 2022-06-24 |
| Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies (NCT05417594) | AstraZeneca | 2022-06-24 |
| The Pharmacokinetics (PK), Pharmacodynamics(PD), Safety, Tolerability of SR1375 in Healthy Volunteers (NCT05421923) | Shanghai SIMR Biotechnology Co., Ltd. | 2022-06-24 |
| Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma (NCT05226494) | NanoPharmaceuticals LLC | 2022-06-23 |
| Study of Safety, PK, and Efficacy of Multiple Ascending Doses of HZBio1 in Patients With Gout (NCT07752810) | Hangzhou Grand Biologic Pharmaceutical, Inc. | 2022-06-23 |
| Tislelizumab Combined with Mitoxantrone Hydrochloride Liposome in Extranodal Natural Killer/T Cell Lymphoma (NCT05464433) | Sun Yat-sen University | 2022-06-23 |
| A Study in Healthy Men to Compare Two Different Oral Formulations of BI 1810631 and to Test How Food or Rabeprazole Influence the Amount of BI 1810631 in the Blood (NCT05380947) | Boehringer Ingelheim | 2022-06-23 |
| A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers (NCT05453786) | SK Chemicals Co., Ltd. | 2022-06-23 |
| Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy (NCT04113382) | Ferring Pharmaceuticals | 2022-06-23 |
| SynOV1.1 Intratumoral Injection Study (NCT04612504) | Beijing Syngentech Co., Ltd. | 2022-06-23 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect and DDI of Ascending Doses of the MEK Inhibitor Zapnometinib (NCT05555823) | Atriva Therapeutics GmbH | 2022-06-23 |
| Ascending Glycan Dietary Supplementation in Healthy Adults (NCT04466761) | University of California, Davis | 2022-06-23 |
| The Effects of Dietary Supplementation on Serum Protein Glycosylation (NCT05040204) | University of California, Davis | 2022-06-23 |
| A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis (NCT05344157) | Xindu Pty Ltd | 2022-06-22 |
| A First in Human (FIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DR10624 (NCT05378893) | Zhejiang Doer Biologics Co., Ltd. | 2022-06-22 |
| A Study of Two Macitentan Formulations in Healthy Adult Participants (NCT05433675) | Actelion | 2022-06-22 |
| A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors (NCT05396391) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2022-06-22 |
| Study of AM003 in Patients With Locally Advanced and Metastatic Solid Tumors (NCT06258330) | Aummune Ltd. | 2022-06-22 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema (NCT06850922) | Genentech, Inc. | 2022-06-22 |
| A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19 (NCT05386472) | Pfizer | 2022-06-22 |
| An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmacokinetics (NCT05478278) | Usona Institute | 2022-06-22 |
| Safety and Efficacy of CKDB-501B in Subjects With Moderate-to-severe Glabellar Lines (NCT05428930) | CKD Bio Corporation | 2022-06-22 |
| A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or Together (NCT05435677) | Novo Nordisk A/S | 2022-06-22 |
| A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet (NCT05429593) | Novo Nordisk A/S | 2022-06-22 |
| A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors (NCT05773937) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2022-06-21 |
| A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer (NCT05451849) | TCR2 Therapeutics | 2022-06-21 |
| Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393 (NCT05274880) | Chong Kun Dang Pharmaceutical | 2022-06-21 |
| A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study) (NCT05462106) | AC Immune SA | 2022-06-21 |
| A Study of Diet Influence of AL8326 in Chinese Healthy Adult Subjects (NCT05486598) | Advenchen Laboratories Nanjing Ltd. | 2022-06-21 |
| Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects (NCT05467709) | Concert Pharmaceuticals | 2022-06-21 |
| Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection (NCT05010577) | BiomX, Inc. | 2022-06-21 |
| Adenosine 2A Receptor Antagonism and AIH in ALS (NCT05377424) | University of Florida | 2022-06-21 |
| Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML) (NCT04926285) | University of Illinois at Chicago | 2022-06-21 |
| Food Effect Study of VHX-896 in Healthy Volunteers (NCT06803290) | Vanda Pharmaceuticals | 2022-06-21 |
| A Study of Single and Multiple Doses of Different Formulations of a Prostacyclin Receptor Agonist (NCT05427162) | Actelion | 2022-06-21 |
| A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection (NCT06311734) | Shanghai Longwood Biopharmaceuticals Co., Ltd. | 2022-06-21 |
| IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors (NCT05076591) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2022-06-20 |
| PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel (NCT05041699) | International Partnership for Microbicides, Inc. | 2022-06-20 |
| Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma (NCT05089370) | University of Colorado, Denver | 2022-06-20 |
| A Study Assessing the Safety, Tolerability, Immunogenicity of COVID-19 Vaccine Candidate PRIME-2-CoV_Beta, Orf Virus Expressing SARS-CoV_2 Spike and Nucleocapsid Proteins (NCT05367843) | Speransa Therapeutics | 2022-06-20 |
| A Study of MCARH109 and MCARH125 in People With Multiple Myeloma (NCT05431608) | Memorial Sloan Kettering Cancer Center | 2022-06-20 |
| A Study to Assess the Safety and Pharmacokinetics of Single Ascending Subcutaneous and Intravenous Doses of DS-2325a in Healthy Subjects (NCT05388903) | Daiichi Sankyo | 2022-06-20 |
| Loncastuximab Tesirine and Venetoclax for Relapsed/ Refractory Non-Hodgkin Lymphoma (NCT05053659) | Paolo Caimi, MD | 2022-06-20 |
| Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR) (NCT05371132) | City of Hope Medical Center | 2022-06-20 |
| A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or Lymphoma (NCT05390528) | Shanghai Henlius Biotech | 2022-06-20 |
| Genetically Engineered Cells (MUC1-Activated T-Cells) for the Treatment of MUC1 Positive Recurrent or Refractory Multiple Myeloma (NCT05411497) | Mayo Clinic | 2022-06-20 |
| 177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors (NCT05475210) | Molecular Targeting Technologies, Inc. | 2022-06-18 |
| Phase I Clinical Trial of GEN2-Recombinant COVID-19 Vaccine (CHO Cells) in Healthy People Aged 18 and Above (NCT05408312) | National Vaccine and Serum Institute, China | 2022-06-18 |
| Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects (NCT05354752) | Jiangsu vcare pharmaceutical technology co., LTD | 2022-06-18 |
| Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer (NCT05142189) | BioNTech SE | 2022-06-17 |
| Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma (NCT05363800) | Jiangsu HengRui Medicine Co., Ltd. | 2022-06-17 |
| Bioequivalence Study of Two Formulations of Tablets Ramipril 10 mg in Healthy Volunteers Under Fasting Conditions (NCT05438316) | Pharmtechnology LLC | 2022-06-17 |
| A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7) (NCT04970901) | ADC Therapeutics S.A. | 2022-06-17 |
| Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer (NCT05430009) | VA Ann Arbor Healthcare System | 2022-06-17 |
| A Study to Understand the Effect of Low-Fat and High-Fat Meals on the Medicine Called PF-07284890 in Healthy Adults (NCT05349864) | Pfizer | 2022-06-17 |
| A Study of ZG005 in Patients With Advanced Solid Tumors (NCT06233292) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2022-06-17 |
| A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants (NCT05409157) | Bristol-Myers Squibb | 2022-06-17 |
| Pharmacokinetic and Safety Study of Naltrexone Release From Subcutaneous BICX104 Pellets Compared to Vivitrol Injections (NCT04828694) | BioCorRx Inc | 2022-06-17 |
| A Study of PN20 in Healthy Adult Volunteers (NCT06523088) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2022-06-16 |
| An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes (NCT04590872) | City of Hope Medical Center | 2022-06-16 |
| A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer (NCT05232851) | Mayo Clinic | 2022-06-16 |
| A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001) (NCT05382325) | Merck Sharp & Dohme LLC | 2022-06-16 |
| Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer (NCT05156905) | University of California, San Diego | 2022-06-16 |
| A Microneurography (MNG) Study of VX-150 in Healthy Participants (NCT05418712) | Vertex Pharmaceuticals Incorporated | 2022-06-16 |
| Safety, Tolerability, and Pharmacokinetics of Q-Griffithsin Intranasal Spray (NCT05437029) | Kenneth Palmer | 2022-06-15 |
| Relative Bioavailability and Pharmacodynamics of HSK7653 in Healthy Volunteers (NCT06003088) | Haisco Pharmaceutical Group Co., Ltd. | 2022-06-15 |
| Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL (NCT05453669) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-06-15 |
| A Phase I/II Study of AMG 510 in Combination With MVASI in Patients With Advanced, Unresectable or Metastatic KRAS G12C Mutant NSCLC With Asymptomatic Brain Metastasis (NCT05180422) | Criterium, Inc. | 2022-06-15 |
| MRI-Guided Focused Ultrasound Radiosensitization for Patients With Malignant Melanoma and Non Melanoma Skin Cancer (NCT05620290) | Sunnybrook Health Sciences Centre | 2022-06-15 |
| Mass Balance Study of [14C]X842 in Healthy Adult Male Subjects (NCT07107672) | Jiangsu Sinorda Biomedicine Co., Ltd | 2022-06-15 |
| Safety and Toxicity Study of IMM27M in Patients With Advanced Solid Tumor (NCT05235438) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2022-06-15 |
| Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas (NCT05105412) | National Health Research Institutes, Taiwan | 2022-06-15 |
| Effects of Flourish HEC and BioGenesis to Improve Conception (NCT05390606) | Vaginal Biome Science | 2022-06-15 |
| Study to Evaluate HT-6184 in Healthy Subjects (NCT05447546) | Halia Therapeutics, Inc. | 2022-06-15 |
| ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors (NCT05405595) | Adagene Inc | 2022-06-15 |
| A PK Study Comparing MB05, EU-sourced Synagis® and US-sourced Synagis® in Healthy Volunteers. (NCT05121246) | mAbxience Research S.L. | 2022-06-15 |
| SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (NCT05552807) | Sinocelltech Ltd. | 2022-06-15 |
| Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer (NCT05410821) | The First Affiliated Hospital of Xiamen University | 2022-06-15 |
| APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT05186012) | Ascentage Pharma Group Inc. | 2022-06-14 |
| Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants (NCT05387941) | Region Skane | 2022-06-14 |
| Decreasing Polypharmacy in Older Adults With Curable Cancers Trial (NCT05046171) | University of Rochester | 2022-06-14 |
| A Study to Evaluate Molnupiravir (MK-4482) in Participants With Moderate Hepatic Impairment (MK-4482-016) (NCT05386589) | Merck Sharp & Dohme LLC | 2022-06-14 |
| Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid Leukemia (NCT05445011) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2022-06-14 |
| A Phase 1 Study of Single and Multiple Intravenous Doses of SM17 in Healthy Subjects (NCT05332834) | SinoMab BioScience Ltd | 2022-06-14 |
| A Study to Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body in Participants With Mild or Moderate Reduction of Liver Function Compared to Participants With Normal Liver Function (NCT05419635) | Bayer | 2022-06-14 |
| A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT) (NCT05426369) | Sichuan Clover Biopharmaceuticals, Inc. | 2022-06-14 |
| A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia (NCT05345938) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-06-14 |